US 12,110,345 B2
Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2
Scott M. Duncan, Bedford, MA (US)
Assigned to Stealth BioTherapeutics Inc., Needham, MA (US)
Filed by Stealth BioTherapeutics Inc., Needham, MA (US)
Filed on Aug. 8, 2023, as Appl. No. 18/231,483.
Application 17/225,565 is a division of application No. 16/603,117, granted, now 11,034,724, issued on Jun. 15, 2021, previously published as PCT/US2018/025990, filed on Apr. 4, 2018.
Application 18/231,483 is a continuation of application No. 17/225,565, filed on Apr. 8, 2021, granted, now 11,773,136.
Claims priority of provisional application 62/481,766, filed on Apr. 5, 2017.
Prior Publication US 2024/0140990 A1, May 2, 2024
Int. Cl. C30B 29/58 (2006.01); C07K 5/11 (2006.01)
CPC C07K 5/1019 (2013.01) [C30B 29/58 (2013.01); C07B 2200/13 (2013.01)] 18 Claims
 
1. A crystalline form of the freebase of Compound (I),

OG Complex Work Unit Chemistry
(Boc)-D-Arg-DMT-Lys(Boc)-Phe-NH2).